Articles

Condyloma acuminata prevalence, clinical characteristics, and associated malignancies in Saudi patients at a tertiary care center

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 26 March 2026
161
Views
70
Downloads

Authors

Condyloma acuminata (CA) are benign anogenital warts caused by the human papillomavirus (HPV). Worldwide, HPV is the most common sexually transmitted disease (STD). Data from Saudi Arabia (SA) remains limited. This study aims to assess CA prevalence, clinical characteristics, co-existing STDs, fertility issues, and malignancies at the tertiary care center King Abdulaziz Medical City (KAMC), Riyadh, SA. A total of 118 patients diagnosed with CA were included. RStudio (version 2024.9.1.394, Boston, MA, USA) with R version 4.4.2. was utilized for statistical analysis. Among 15,016 patients attending the Dermatology Department during the study period, 118 were diagnosed with CA, constituting a prevalence of 0.79%. The majority of patients were male (n=69; 58.5%), with a median age of 33 years at the time of diagnosis. Perianal (n=40; 33.9%) and vulvar (n=39; 33.1%) regions were the most affected sites. Smoking (n=30; 25.4%), extramarital sexual activity (n=5; 8.8%), and abnormal Pap smear results (n=6; 5.7%) were significant findings. Immunodeficiency was noted in 3 patients (2.5%), and HPV vaccination status was low (n=6; 5.7%). Anogenital warts were found in 115 patients (97.5%), with Buschke-Löwenstein tumors in 3 patients (2.5%). Infertility was reported in 10 patients (17.2%); the majority had primary infertility (n=8; 80.0%). HPV vaccination, awareness, and prevention strategies are necessary to reduce CA burden and complications.

Downloads

Download data is not yet available.

Citations

1. Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 2013;13:39.
2. Pennycook KB, McCready TA. Condyloma Acuminata. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
3. Kaderli R, Schnüriger B, Brügger LE. The impact of smoking on HPV infection and the development of anogenital warts. Int J Colorectal Dis 2014;29:899-908.
4. Fleischer AB Jr, Parrish CA, Glenn R, Feldman SR. Condylomata acuminata (genital warts): patient demographics and treating physicians. Sex Transm Dis 2001;28:643-7.
5. Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect 2013;66:207-17.
6. Park IU, Introcaso C, Dunne EF. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 2015;61:S849-55.
7. Lewis RM, Gargano JW, Unger ER, et al. Genital Human Papillomavirus Prevalence Over the Lifespan Among Females and Males in a National Cross-Sectional Survey, United States, 2013-2016. Sex Transm Dis 2021;48:855-63.
8. Tyros G, Mastraftsi S, Gregoriou S, Nicolaidou E. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination. Int J STD AIDS 2021;32:4-13.
9. Peder LD de, Silva CM da, Madeira HS, et al. Predictors associated with and the prevalence of condylomata acuminata infection among people in Southern Brazil. HSJ 2021;11:22-30.
10. Yuan H, Li R, Lv J, et al. Epidemiology of human papillomavirus on condyloma acuminatum in Shandong Province,China. Hum Vaccin Immunother 2023;19:2170662.
11. Ren X, Qiu L, Ke W, et al. Awareness and acceptance of HPV vaccination for condyloma acuminata among men who have sex with men in China. Hum Vaccin Immunother 2022;18:2115267.
12. Vaccarella S, Franceschi S, Herrero R, et al; IARC HPV Prevalence Surveys Study Group. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15:326-33.
13. Nordenvall C, Chang ET, Adami HO, Ye W. Cancer risk among patients with condylomata acuminata. Int J Cancer 2006;119:888-93.
14. Sporkert M, Rübben A. Buschke-Löwenstein-Tumor [Buschke-Lowenstein tumors]. Hautarzt 2017;68:199-203.
15. Chu QD, Vezeridis MP, Libbey NP, Wanebo HJ. Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum 1994;37:950-7.
16. Purwoko IH, Karim PL, Nugroho SA, et al. Risk Factors for HIV-positive Status In Condyloma Acuminata. J Gen Proced Dermatol Venereol Indones 2022;6.
17. Svidler López L, La Rosa L. Human Papilloma Virus Infection and Anal Squamous Intraepithelial Lesions. Clin Colon Rectal Surg 2019;32:347-57.
18. Qaderi K, Mirmolaei ST, Geranmayeh M, et al. ‘Does HPV affect my fertility?’ Reproductive concerns of HPV-positive women: a qualitative study. Reprod Health 2021;18:72.
Dana Alessa, Division of Dermatology, Department of Medicine, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh

King Abdullah International Medical Research Center, Ministry of National Guard, Riyadh, Saudi Arabia.

How to Cite



1.
Alowairdhi YA, Alrubaiaan MT, Alrashid S, Alessa D. Condyloma acuminata prevalence, clinical characteristics, and associated malignancies in Saudi patients at a tertiary care center. Dermatol Reports [Internet]. 2026 Mar. 26 [cited 2026 Apr. 18];. Available from: https://journals.pagepress.net/dr/article/view/10465